[{"Assets_0_Q3_USD":63139000.0,"CommonStockSharesOutstanding_0_Q3_shares":39945000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-36983000.0,"NetIncomeLoss_3_Q3_USD":-49567000.0,"NetIncomeLoss_1_Q3_USD":-23126000.0,"StockholdersEquity_0_Q3_USD":40985000.0,"Ticker":"VSTM","CIK":"1526119","name":"VERASTEM, INC.","OfficialName":"Verastem Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309307156.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]